天津医药
天津醫藥
천진의약
TIANJIN MEDICAL JOURNAL
2015年
2期
186-188
,共3页
宫颈上皮内瘤样病变%宫颈癌%高危型人乳头瘤病毒%HPV E6/E7 mRNA%支链DNA技术
宮頸上皮內瘤樣病變%宮頸癌%高危型人乳頭瘤病毒%HPV E6/E7 mRNA%支鏈DNA技術
궁경상피내류양병변%궁경암%고위형인유두류병독%HPV E6/E7 mRNA%지련DNA기술
cervical intraepithelial neoplasia%uterine cervical neoplasms%high-risk human papilloma virus%HPV E6/E7 mRNA%branched DNA technology
目的:探讨人乳头状瘤病毒(HPV)E6/E7 mRNA检测对高危型人乳头瘤病毒(HR-HPV)感染宫颈病变筛查的临床价值。方法选择265例HR-HPV感染者,其中100例病理结果为正常宫颈/慢性炎症(对照组),88例宫颈上皮内瘤变(CIN)Ⅰ级,33例CINⅡ级,28例CINⅢ级,16例宫颈癌患者的宫颈脱落细胞标本,采用支链DNA(b-DNA)技术检测HPV E6/E7 mRNA的表达情况。结果 CINⅡ级(81.82%)、CINⅢ级(89.29%)、宫颈癌组(100.00%)的HPV E6/E7 mRNA阳性率高于对照组(20.00%)和CINⅠ级(35.23%),差异有统计学意义,其余各组间比较差异无统计学意义;CINⅡ级、CINⅢ级、宫颈癌组的HPV E6/E7 mRNA表达量也高于对照组和CINⅠ级,差异有统计学意义,其余各组间比较差异无统计学意义;高级别鳞状上皮内瘤变(HSIL)和癌组的HPV E6/E7 mRNA阳性率及表达量显著高于正常、非典型鳞状细胞(ASC)和低级别鳞状上皮内瘤变(LSIL)组(P<0.05)。结论 HPV E6/E7 mRNA的表达可能提示了病毒的活性和病变的进展程度,可能成为筛查出高级别宫颈病变的有效指标,可以作为宫颈癌前病变筛查的辅助方法。
目的:探討人乳頭狀瘤病毒(HPV)E6/E7 mRNA檢測對高危型人乳頭瘤病毒(HR-HPV)感染宮頸病變篩查的臨床價值。方法選擇265例HR-HPV感染者,其中100例病理結果為正常宮頸/慢性炎癥(對照組),88例宮頸上皮內瘤變(CIN)Ⅰ級,33例CINⅡ級,28例CINⅢ級,16例宮頸癌患者的宮頸脫落細胞標本,採用支鏈DNA(b-DNA)技術檢測HPV E6/E7 mRNA的錶達情況。結果 CINⅡ級(81.82%)、CINⅢ級(89.29%)、宮頸癌組(100.00%)的HPV E6/E7 mRNA暘性率高于對照組(20.00%)和CINⅠ級(35.23%),差異有統計學意義,其餘各組間比較差異無統計學意義;CINⅡ級、CINⅢ級、宮頸癌組的HPV E6/E7 mRNA錶達量也高于對照組和CINⅠ級,差異有統計學意義,其餘各組間比較差異無統計學意義;高級彆鱗狀上皮內瘤變(HSIL)和癌組的HPV E6/E7 mRNA暘性率及錶達量顯著高于正常、非典型鱗狀細胞(ASC)和低級彆鱗狀上皮內瘤變(LSIL)組(P<0.05)。結論 HPV E6/E7 mRNA的錶達可能提示瞭病毒的活性和病變的進展程度,可能成為篩查齣高級彆宮頸病變的有效指標,可以作為宮頸癌前病變篩查的輔助方法。
목적:탐토인유두상류병독(HPV)E6/E7 mRNA검측대고위형인유두류병독(HR-HPV)감염궁경병변사사적림상개치。방법선택265례HR-HPV감염자,기중100례병리결과위정상궁경/만성염증(대조조),88례궁경상피내류변(CIN)Ⅰ급,33례CINⅡ급,28례CINⅢ급,16례궁경암환자적궁경탈락세포표본,채용지련DNA(b-DNA)기술검측HPV E6/E7 mRNA적표체정황。결과 CINⅡ급(81.82%)、CINⅢ급(89.29%)、궁경암조(100.00%)적HPV E6/E7 mRNA양성솔고우대조조(20.00%)화CINⅠ급(35.23%),차이유통계학의의,기여각조간비교차이무통계학의의;CINⅡ급、CINⅢ급、궁경암조적HPV E6/E7 mRNA표체량야고우대조조화CINⅠ급,차이유통계학의의,기여각조간비교차이무통계학의의;고급별린상상피내류변(HSIL)화암조적HPV E6/E7 mRNA양성솔급표체량현저고우정상、비전형린상세포(ASC)화저급별린상상피내류변(LSIL)조(P<0.05)。결론 HPV E6/E7 mRNA적표체가능제시료병독적활성화병변적진전정도,가능성위사사출고급별궁경병변적유효지표,가이작위궁경암전병변사사적보조방법。
Objective To explore the clinical value of examining HPV E6/E7 mRNA level in assessing cervical le?sions infected with high-risk human papillomavirus (HR-HPV). Methods The cervical epithelial cells were collected from 265 patients with HR-HPV infection, including 100 cases of neoplasia free/inflammation group (control group), 88 cas?es of cervical intraepithelial neoplasia (CIN)Ⅰ, 33 cases of CINⅡ, 28 cases of CINⅢand 16 cases of cervical carcinoma and the transcription of HPV E6/E7 mRNA level was examined using branched DNA (b-DNA) technology. Results The positive rate HPV E6/E7 mRNA were higher in CIN Ⅱ(81.82%), CINⅢ(89.29%) and cervical cancer group (100.00%) than tthat in control group (20.00%) and CINⅠ(35.23%) with significant difference, and there were no significant differences between other groups;The positive rate and transcription level of HPV E6/E7 mRNA in HSIL (high grade squamous intraepi?thelial lesion)and cancer group were significantly higher than normal, ASC(atypical squamous cell carcinoma) and LSIL(low grade squamous intraepithelial lesion) group (P<0.05). Conclusion The transcription level of HPV E6/E7 mRNA may re?flect the activity of the virus and the progression of disease, and could be use as an effective indicator to screen high grade cervical pathological changes and a complementary method of cervical lesion screening.